| Literature DB >> 31880177 |
Abstract
Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system, causing inflammation, demyelination, and neurodegeneration. Infection can play a role in its etiology. Herein, a review is presented of studies that have reported an association between infection and MS risk in countries of the Arabian Gulf region. Searches of the PubMed, Google Scholar, and Science Direct databases were carried out using various search terms, and relevant studies published through January 2019 on the epidemiology of MS in Gulf Cooperation Council countries identified. MS has been found to be associated with measles in Saudi Arabia and Epstein-Barr virus in Kuwait whereas no association has been identified between risk of MS and varicella-zoster virus, mumps, or human herpesvirus-6. However, few epidemiological studies on this topic have been conducted in countries of the Gulf region. Longitudinal and serological studies to establish robust evidence between infection and risk of MS are highly recommended, and a regional MS registry is needed.Entities:
Keywords: Epstein–Barr virus; Gulf Cooperation Council countries; Multiple sclerosis; epidemiological study; infection; measles
Mesh:
Year: 2019 PMID: 31880177 PMCID: PMC7607054 DOI: 10.1177/0300060519884151
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Gulf Cooperation Council (GCC) countries.
Figure 2.Flow chart of strategy used for article selection.
Studies in Gulf Cooperation Council countries of multiple sclerosis and reporting infection.
| Reported infection | Author and country | Age range or (mean) | Methods | MS patients (n) | Controls (n) | OR (95% CI) |
|
|---|---|---|---|---|---|---|---|
| Measles | Halawani AT et al., 2018[ | 18–57 years | Face-to-face interview | 80 | 160 | 3.76(1.46–9.70) | <0.05 |
| Al Wutayd et al., 2018[ | 18–69 years | SAQ | 307 | 307 | 3.77 (2.05–6.96) | <0.001 | |
| Al Afasy HH et al., 2013[ | (33.8 years) | Face-to-face interview | 101 | 202 | NI† | NS | |
| VZV | Halawani AT et al., 2018[ | 18–57 years | Face-to-face interview | 80 | 160 | 1.25 (0.73–2.15) | NS |
| Al Wutayd et al., 2018[ | 18–69 years | SAQ | 307 | 307 | 0.90 (0.65–1.24) | NS | |
| Al Afasy HH et al., 2013[ | (33.8 years) | Face-to-face interview | 101 | 202 | NI | NS | |
| Mumps | Al Afasy HH et al., 2013[ | (33.8 years) | Face-to-face interview | 101 | 202 | NI | NS |
| EBV | Al Afasy HH et al., 2013[ | (33.8 years) | Face-to-face interview | 101 | 202 | NI | NS |
| Al-Temaimi et al., 2015[ | 14–60 years | ELISA assay | 141 | 40 | 22.59(5.07–40.45) | 0.008 | |
| HHV-6 | Al-Shammari et al., 2003[ | NI | Serum PCR | 24 | 33 | NI | NS |
Abbreviations: SAQ: self-administered questionnaire, NI: no information, EBV: Epstein–Barr Virus, HHV-6: human herpesvirus-6, VZV: varicella-zoster virus, MS: multiple sclerosis, PCR: polymerase chain reaction, ELISA: enzyme-linked immunosorbent assay, NS: not significant, OR: odds ratio, CI: confidence interval.